Director and 10% owner Scott M Rocklage sold $7.0M of Aprea Therapeutics, Inc.

Sold$7,044,412

$28.75Price

245,000Shares

−75%Stake

What APRE did after the filing

Prices for APRE after this filing aren't in yet.

Traded Thu, Jun 11. Filed Mon, Jun 15, 5:13 PM ET, after the close. Not investment advice.